InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,044.32
(
0.44%
)
US TECH 100
17,109.60
(
0.45%
)
Dow Jones
37,991.67
(
0.63%
)
Brent Oil
86.71
(
-0.32%
)
Bitcoin
63,730.82
(
3.99%
)
Post# of 75087
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

zigzagman

Send PM Follow Ignore
Followers 646
Posts 144549
Boards Moderated 1
Alias Born 05/19/2007

zigzagman

Re: None

Tuesday, 01/02/2018 2:02:04 PM

Tuesday, January 02, 2018 2:02:04 PM

Post# of 75087
$PSID's CEO projects consolidated year-over-year revenue growth of more than 30% for the 2017 fourth quarter and 2018 first quarter due to a strong backlog of business and pipeline opportunities for its mobile labs and medical device businesses. PositiveID operates in three segments: Mobile Labs, comprised of its E-N-G Mobile Systems, Inc. subsidiary, a specialty vehicle manufacturer; Medical Devices, comprised of its Thermomedics subsidiary, which markets the Caregiver® non-contact thermometer; and Molecular Diagnostics, comprised of its ExcitePCR Corporation subsidiary, consisting of its FireflyDX family of products for real-time pathogen detection at the point-of-need/point-of-care.

The new CEO interview can be heard at: http://ceolive.tv/positiveid-corp-psid-ceo-discusses-2017-highlights-for-its-molecular-diagnostics-business

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up